WAY TO STEP OUT FROM CANCER

Lynparza 50mg Lynparza 50 мг - это тип таргетной терапии, называемый PARP (пероральный ингибитор поли (аденозиндифосфат-рибоза) полимеразы), который имеет многообещающее противоопухолевое действие у пациентов с метастатическим раком молочной железы и мутацией BRCA зародышевой линии. Капсула Lynparza 50 м г является ферментом, включенным в репарацию ДНК, и будет действовать против рака у людей с наследственными мутациями BRCA1 или BRCA2, которые включают некоторые виды рака яичников, молочной железы и простаты Lynparza 50 мг - это рецептурный препарат, который используется под наблюдением медицинских работников. ПОКАЗАНИЯ Капсула Lynparza 50 мг используется для лечения пациентов с поддерживающей терапией первого ряда BRCAm распространенным раком яичников Линпарза 50 мг используется для лечения пациентов с рецидивирующим раком яичников. Капсула Lynparza 50 мг используется для лечения пациентов с прогрессирующим раком яичника gBRCAm. Линпарза в дозе 50 мг показа

Revolade 12.5mg Revolade 12.5mg ( Eltrombopag  12.5mg)   is a prescription drug which is used under the supervision of the doctor. Revolade 12.5mg tablet ( Eltrombopag  12.5mg tablet)   drug may be used as part of a co-administration therapy. Hence drug may require fortaking it with other medications. INDICATION Revolade 12.5mg ( Eltrombopag  12.5mg)  is mainly indicated for the treatment of patients having : • lower platelet levels due to chronic immune thrombocytopenia • lower platelet counts due to chronic hepatitis C virus infection • Severe aplastic Anemia : • First line treatment of severe aplastic Anemia • Treatment of refractory severe aplastic Anemia DOSAGE Chronic Immune Thrombocytopenia The recommended dose of Revolade has Initial: 50 mg PO qDay Adjust dose to achieve Control platelet count (Plt) >50 x 10^9/L to reduces risk of bleeding;  Revolade 12.5mg ( Eltrombopag  12.5mg)  not to exceed 75 mg/day Chronic Hepatitis C-associated Thrombocytop

Lenvatinib 4mg  Lenvatinib 4mg is also known as tyrosine kinase inhibitor. Lenvatinib 4mg capsule targets something to the cancer cells. Lenvatinib 4mg is well absorbed. In which Food does not affect the range of absorption but lower the rate. Lenvatinib 4mg which is a prescription drug used under proper guidance of medical oncologist. INDICATION • Indicated For the treatment of thyroid cancer which cannot be treated with radioactiveiodine. • Indicated By combined with everolimus  Lenvatinib 4mg  to treat the advanced renal carcinoma in which other drugs failed to be effective. • Indicated For the treatment of hepatocellular primary liver cancer DOSAGE The recommended dose of differentiated thyroid cancer is Lenvatinib 24 mg, it administers by two 10mg and one 4 mg capsules taken orally, Lenvatinib 4mg capsule  once in a day along with or without food. The recommended dose of renal cell carcinomas is Lenvatinib 18 mg, given as one 10mg capsule and two 4 mg capsule

Lenvatinib 10mg Lenvatinib 10mg is also known as tyrosine kinase inhibitor. Lenvatinib 10mg capsule targets something to the cancer cells. Lenvatinib 10mg is well absorbed. In which Food does not affect the range of absorption but lower the rate. Lenvatinib 10mg capsule which is a prescription drug used under proper guidance of medical oncologist. INDICATION • Indicated For the treatment of thyroid cancer which cannot be treated with radioactiveiodine. • Indicated By combined with everolimus to treat the advanced renal carcinoma in which other drugs failed to be effective. • Indicated For the treatment of hepatocellular primary liver cancer DOSAGE The recommended dose of differentiated thyroid cancer is Lenvatinib 24 mg, it administers by two 10mg and one 4 mg capsules taken orally, once in a day along with or without food. The recommended dose of renal cell carcinomas is Lenvatinib 18 mg, given as one 10mg capsule and two 4 mg capsules administrated in combination with 5m

Lynparza 50mg Lynparza 50mg is a type of targeted therapy called a PARP (oral poly (adenosine diphosphate–ribose) polymerase inhibitor)which has promising anti neoplasticaction in patients with metastatic breast cancer and a germline BRCA mutation. Lynparza 50mg capsule is an enzyme included in DNA repair and will act against cancers in people with hereditary BRCA1 or BRCA2 mutations, which involve some ovarian, breast and prostate cancer Lynparza 50mg is a prescription drug which used under the supervision of medical practioners INDICATION Lynparza 50mg capsule is used for the treatment in patients with first line maintenance BRCAm advanced ovarian cancer Lynparza 50mg is used for the treatment in patients with maintenance recurrent ovarian cancer. Lynparza 50mg capsule is used for the treatment in patients withadvanced gBRCAm ovarian cancer Lynparza 50mg is indicated for the treatment in patients with HER2 – negative metastatic breast cancer. DOSAGE Ovarian cancer : M

Revolade 75mg Revolade 75mg ( Eltrombopag  75mg)  is a prescription drug which is used under the supervision of the doctor. Revolade 75mg tablet ( Eltrombopag  75mg tablet)   drug may be used as part of a co-administration therapy. Hence drug may require fortaking it with other medications. INDICATION Revolade 75mg ( Eltrombopag  75mg)  is mainly indicated for the treatment of patients having : • lower platelet levels due to chronic immune thrombocytopenia • lower platelet counts due to chronic hepatitis C virus infection • Severe aplastic Anemia : • First line treatment of severe aplastic Anemia • Treatment of refractory severe aplastic Anemia DOSAGE Chronic Immune Thrombocytopenia The recommended dose of Revolade has Initial: Revolade 75mg ( Eltrombopag  75mg)  50 mg PO qDay Adjust dose to achieve Control platelet count (Plt) >50 x 10^9/L to reduces risk of bleeding; not to exceed 75 mg/day Chronic Hepatitis C-associated Thrombocytopenia The recommended dos

Revolade 50mg Revolade 50mg ( Eltrombopag  50mg)   is a prescription drug which is used under the supervision of the doctor. Revolade 50mg tablet ( Eltrombopag  50mg tablet)   drug may be used as part of a co-administration therapy. Hence drug may require fortaking it with other medications. INDICATION Revolade 50mg ( Eltrombopag  50mg)  is mainly indicated for the treatment of patients having : • lower platelet levels due to chronic immune thrombocytopenia  Revolade 50mg ( Eltrombopag  50mg) • lower platelet counts due to chronic hepatitis C virus infection • Severe aplastic Anemia : • First line treatment of severe aplastic Anemia • Treatment of refractory severe aplastic Anemia DOSAGE Chronic Immune Thrombocytopenia The recommended dose of Revolade has Initial: 50 mg PO qDay Adjust dose to achieve Control platelet count (Plt) >50 x 10^9/L to reduces risk of bleeding; not to exceed 75 mg/day  Revolade 50mg tablet ( Eltrombopag  50mg tablet) Chronic Hepatiti

Revolade 25mg Revolade 25mg ( Eltrombopag 25mg)  is a prescription drug which is used under the guidance of the doctor. Revolade 25mg tablet ( Eltrombopag 25mg tablet)  drug may be used as part of a combination therapy. Thereby drug may need to take it with other medications. INDICATION Revolade 25mg ( Eltrombopag 25mg)  is mainly indicated for the treatment of patients having : • Reduced platelet levels due to chronic immune thrombocytopenia • Reduced platelet counts due to chronic hepatitis C virus infection • Severe aplastic Anemia : • First line treatment of severe aplastic Anemia • Treatment of refractory severe aplastic Anemia DOSAGE Chronic Immune Thrombocytopenia : Indicated only in patients  Revolade 25mg ( Eltrombopag 25mg)  with chronic immune thrombocytopenia whose clinical condition increases bleeding risk Initial:  50 mg PO qDay Adjust dose to achieve and control platelet count (Plt) >50 x 10^9/L to lowers risk of bleeding; not to exceed 75 mg/day

Opdyta 100mg Opdyta 100mg is prescription drug which is used under the supervision of doctor Opdyta 100mg injection belongs to human monoclonal antibody which stops the interaction between PD-1 and its ligands, PD-L1 and PD-L2. Opdyta 100mg is an IgG4 kappa immunoglobulin which has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Opdyta 100mg injection is also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. INDICATION Opdyta 100mg is indicated for the treatment of patients having : • Melanoma • Non-Small Cell Lung Cancer • Kidney (Renal Cell) Cancer DOSAGE Opdyta 100mg injection  recommended dosage for unresectable or metastatic melanoma: As single agent is either 240mg every 2 weeks or 480mg every 4 weeks given as IV infusion over 30 minutes until disease progression or unacceptable tox

Opdyta 40mg Opdyta 40mg is prescription drug which is used under supervision of doctor Opdyta 40mg injection belongs to human monoclonal antibody which stops the interaction between PD-1 and its ligands, PD-L1 and PD-L2. Opdyta 40mg is an IgG4 kappa immunoglobulin which has a calculated molecular mass of 146 kDa. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Opdyta 40mg is also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. INDICATION Opdyta 40mg is indicated for the treatment of patients having : • Melanoma • Non-Small Cell Lung Cancer • Kidney (Renal Cell) Cancer DOSAGE Opdyta recommended dosage for unresectable or metastatic melanoma: As single agent is either 240mg every 2 weeks or 480mg every 4 weeks given as IV infusion over 30 minutes until disease progression or unacceptable toxicity  With ipilimum